News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Erythropoietin Promotes an Immunosuppressive Tumor Microenvironment in Liver Cancer Models – NCI Division of Cancer Biology
Photo: Depositphotos.com
Jul 9, 2025, 19:55

Erythropoietin Promotes an Immunosuppressive Tumor Microenvironment in Liver Cancer Models – NCI Division of Cancer Biology

NCI Division of Cancer Biology shared on LinkedIn:

“An NIH-funded study showed that erythropoietin (a hormone that stimulates the production of red blood cells) secreted by tumor cells promotes an immunosuppressive tumor microenvironment in liver cancer models. It also found that blocking erythropoietin signaling enhances immune responses to tumors.”

NCI Division of Cancer Biology

Title: Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity

Authors: David Kung-Chun Chiu, Xiangyue Zhang, Bowie Yik-Ling Cheng, Qiang Liu, Kazukuni Hayashi, Bo Yu, Ryan Lee, Catherine Zhang, Xiuli An, Jayakumar Rajadas, Nathan E. Reticker-Flynn, Erinn B. Rankin, Edgar G. Engleman

Read full article.

NCI Division of Cancer Biology

Read an insightful article about Liver Cancer.

NCI Division of Cancer Biology

Bo Yu Bowie Yik-Ling Cheng Catherine Zhang David Kung-Chun Chiu Edgar G. Engleman Erinn B. Rankin Jayakumar Rajadas Kazukuni Hayashi liver cancer Nathan E. Reticker-Flynn NCI Division of Cancer Biology Qiang Liu Ryan Lee Xiangyue Zhang Xiuli An
Special Coverage
Blog
Jul 9, 2025, 19:55
Erythropoietin Promotes an Immunosuppressive Tumor Microenvironment in Liver Cancer Models - NCI Division of Cancer Biology
Blog
Jul 9, 2025, 19:35
UF Health Cancer Center Welcomed Nearly 150 Middle and High School Science Teachers From Across the Southeast
Blog
Jul 9, 2025, 19:16
SIOP Provides Scholarships to Nurses Who Have Insufficient Resources to Participate and to Travel to Our Congress
Blog
Jul 9, 2025, 18:36
2nd Synergies Forum Marks Milestone for Pediatric and Young Adult Cancer Advocacy in Europe - ELLOK
Insight
Jul 9, 2025, 18:16
Akhil Kapoor: We Acknowledge and Appreciate the Trial’s Bold and Innovative Approach in Challenging Established Treatment Paradigms
Blog
Jul 9, 2025, 17:59
Afreen Shariff: Ready to Take Cancer Care to New Heights?
Blog
Jul 9, 2025, 17:48
Adrian Pogacian: New Developments in Scanxiety Live Webinar
Blog
Jul 9, 2025, 17:36
Wafaa M Rashed: Ethics, Equity and Policy - Through the Eyes of a Future Leader
Blog
Jul 9, 2025, 17:21
Bernard Fox: What Do Cancer Researchers Need Today?
Blog
Jul 9, 2025, 17:21
Wafik El-Deiry: Are We Ready to Reduce Animal Testing in Cancer Drug Development
Blog
Jul 9, 2025, 17:19
David Skorton: AAMC Viewpoint on a Fourth-Year Medical Student Who Responded to an In-Flight Medical Emergency
Blog
Jul 9, 2025, 17:11
Oliver Bogler: Essential Steps for Your Research Proposal